Surgery as palliative treatment for distant metastases of melanoma

I. L. Wornom, J. W. Smith, S. J. Soong, R. McElvein, M. M. Urist, C. M. Balch

Research output: Contribution to journalArticlepeer-review

Abstract

Sixty-five patients with distant metastatic melanoma amenable to surgical treatment had excision of 94 metastatic lesions from the brain, lung, abdomen, distant subcutaneous sites, and distant lymph nodes. Relief of symptoms, if present, was obtained after excision of 77% of brain metastases, 100% of lung metastases, 88% of distant lymph node and subcutaneous metastases, and 100% of abdominal metastases. Median survival after excision of brain metastases was 8 months, lung metastases 9 months, abdominal metastases 8 months, and distant subcutaneous and lymph node metastases 15 months. Sixteen per cent of patients lived for 2 years or longer. These results demonstrated that surgery can achieve an effective local disease control in selected patients with distant melanoma metastases and that a few have a relatively long-term survival.

Original languageEnglish (US)
Pages (from-to)181-185
Number of pages5
JournalAnnals of surgery
Volume204
Issue number2
DOIs
StatePublished - 1986
Externally publishedYes

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Surgery as palliative treatment for distant metastases of melanoma'. Together they form a unique fingerprint.

Cite this